Baldwin Wealth Partners’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-347
Closed -$235K 238
2025
Q4
$235K Hold
347
0.02% 227
2025
Q3
$222K Buy
+347
New +$211K 0.01% 216
2024
Q4
Sell
-350
Closed -$177K 605
2024
Q3
$177K Buy
350
+268
+327% +$130K 0.01% 348
2024
Q2
$40K Sell
82
-20
-20% -$10K ﹤0.01% 380
2024
Q1
$55.1K Hold
102
﹤0.01% 356
2023
Q4
$56.6K Hold
102
﹤0.01% 362
2023
Q3
$44.6K Hold
102
﹤0.01% 411
2023
Q2
$51.2K Sell
102
-3,162
-97% -$1.52M ﹤0.01% 412
2023
Q1
$1.63M Sell
3,264
-172
-5% -$82.3K 0.14% 97
2022
Q4
$1.4M Sell
3,436
-370
-10% -$144K 0.13% 103
2022
Q3
$1.24M Sell
3,806
-29
-0.8% -$10.7K 0.17% 60
2022
Q2
$1.34M Sell
3,835
-571
-13% -$233K 0.17% 62
2022
Q1
$2.41M Sell
4,406
-801
-15% -$421K 0.26% 55
2021
Q4
$3.43M Buy
5,207
+239
+5% +$150K 0.34% 49
2021
Q3
$3.09M Sell
4,968
-296
-6% -$199K 0.34% 49
2021
Q2
$3.32M Sell
5,264
-1,039
-16% -$574K 0.36% 49
2021
Q1
$3.08M Sell
6,303
-3,039
-33% -$1.52M 0.37% 48
2020
Q4
$4.67M Sell
9,342
-5,910
-39% -$2.64M 0.59% 48
2020
Q3
$6M Sell
15,252
-271
-2% -$100K 0.82% 39
2020
Q2
$5.13M Sell
15,523
-689
-4% -$199K 0.75% 42
2020
Q1
$3.93M Buy
16,212
+1,725
+12% +$450K 0.69% 47
2019
Q4
$3.78M Buy
14,487
+6,235
+76% +$1.64M 0.53% 53
2019
Q3
$2.24M Buy
8,252
+3,670
+80% +$1.02M 0.34% 59
2019
Q2
$1.26M Buy
+4,582
New +$1.13M 0.19% 74
2017
Q1
Sell
-9
Closed -$1K 516
2016
Q4
$1K Buy
+9
New +$1.03K ﹤0.01% 501

Other funds holding IDXX

Baldwin Wealth Partners's IDXX Position: Q1 2026 in Review

Baldwin Wealth Partners sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 347 shares — an estimated $235K sold.

Baldwin Wealth Partners first reported a position in IDXX in Q4 2016 and held it in 25 quarters. The position peaked at $6M in Q3 2020. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Baldwin Wealth Partners reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Baldwin Wealth Partners sold 347 Idexx Laboratories shares in Q1 2026, an estimated $235K.
  • Baldwin Wealth Partners first reported a position in Idexx Laboratories in Q4 2016 and held it in 25 quarters.
  • Baldwin Wealth Partners's Idexx Laboratories position peaked at $6M in Q3 2020.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Baldwin Wealth Partners's 13F filing for Q1 2026, filed 14 Apr 2026.